Toll-like Receptor Expression and Activation in Astroglia: Differential Regulation by HIV-1 Tat, gp120, and Morphine

REFERENCES

• Akira, S., Kishimoto, T. (1992). IL-6 and NF-IL-6 in acute phase response and viral infection. Immunol. Rev. 313:47–50.
   Google Scholar
• Akira, S., Hoshino, K., Kaisho, T. (2000). The role of Toll-like receptors and MyD88 in innate immune responses. J. Endotoxin Res. 6:383–387.
   PubMedGoogle Scholar
• Akira, S., Yamamoto, M., Takeda, K. (2003). Role of adapters in Toll-like receptor signalling. Biochem. Soc. Trans. 31:637–642.
   PubMed Web of Science ®Google Scholar
• Ashkar, A.A., Bauer, S., Mitchell, W.J., Vieira, J., Rosenthal, K.L. (2003). Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2. J Virol 77: 8948–8956.
   PubMed Web of Science ®Google Scholar
• Ashkar, A.A., Yao, X.D., Gill, N., Sajic, D., Patrick, A.J., Rosenthal, K.L. (2004). Toll-like receptor (TLR)-3, but not TLR4, agonist protects against genital herpes infection in the absence of inflammation seen with CpG DNA. J. Infect. Dis. 190:1841–1849.
   PubMed Web of Science ®Google Scholar
• Bachis, A., Cruz, M.I., Mocchetti, I. (2010). M-tropic HIV envelope protein gp120 exhibits a different neuropathological profile than T-tropic gp120 in rat striatum. Eur. J. Neurosci. 32:570–578.
   Google Scholar
• Bafica, A., Scanga, C.A., Schito, M., Chaussabel, D., Sher, A. (2004). Influence of coinfecting pathogens on HIV expression: Evidence for a role of Toll-like receptors. J. Immunol. 172:7229–7234.
   PubMed Web of Science ®Google Scholar
• Bal-Price, A., Brown, G.C. (2001). Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J. Neurosci. 21:6480–6491.
   PubMed Web of Science ®Google Scholar
• Becher, B., Prat, A., Antel, J.P. (2000). Brain-immune connection: Immuno-regulatory properties of CNS-resident cells. Glia 29:293–304.
   PubMed Web of Science ®Google Scholar
• Bell, J.E., Brettle, R.P., Chiswick, A., Simmonds, P. (1998). HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement. Brain 121:2043–2052.
   PubMed Web of Science ®Google Scholar
• Bochud, P.Y., Hersberger, M., Taffe, P., Bochud, M., Stein, C.M., Rodrigues, S.D., Calandra, T., Francioli, P., Telenti, A., Speck, R.F., Aderem, A. (2007). Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection. AIDS 21:441–446.
   PubMed Web of Science ®Google Scholar
• Bonnet, M.P., Beloeil, H., Benhamou, D., Mazoit, J.X., Asehnoune, K. (2008). The mu opioid receptor mediates morphine-induced tumor necrosis factor and interleukin-6 inhibition in toll-like receptor 2-stimulated monocytes. Anesth. Analg. 106:1142–1149.
   PubMed Web of Science ®Google Scholar
• Borysiewicz, E., Fil, D., Konat, G.W. (2009). Rho proteins are negative regulators of TLR2, TLR3, and TLR4 signaling in astrocytes. J. Neurosci. Res. 87:1565–1572.
   Google Scholar
• Bowman CC, Rasley A, Tranguch SL, Marriott I (2003) Cultured astrocytes express toll-like receptors for bacterial products. Glia 43:281–291.
   PubMed Web of Science ®Google Scholar
• Brosnan, C.F., Battistini, L., Raine, C.S., Dickson, D.W., Casadevall, A., Lee, S.C. (1994). Reactive nitrogen intermediates in human neuropathology: An overview. Dev. Neurosci. 16:152–161.
   PubMed Web of Science ®Google Scholar
• Bsibsi, M., Ravid, R., Gveric, D., van Noort, J.M. (2002) Broad expression of Toll-like receptors in the human central nervous system. J. Neuropathol. Exp. Neurol. 61:1013–1021.
   PubMed Web of Science ®Google Scholar
• Bsibsi, M., Persoon-Deen, C., Verwer, R.W., Meeuwsen, S., Ravid, R., van Noort, J.M. (2006). Toll-like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators. Glia 53:688–695.
   PubMed Web of Science ®Google Scholar
• Carpentier, P.A., Begolka, W.S., Olson, J.K., Elhofy, A., Karpus, W.J., Miller, S.D. (2005). Differential activation of astrocytes by innate and adaptive immune stimuli. Glia 49:360–374.
   PubMed Web of Science ®Google Scholar
• Carpentier, P.A., Williams, B.R., Miller, S.D. (2007). Distinct roles of protein kinase R and toll-like receptor 3 in the activation of astrocytes by viral stimuli. Glia 55:239–252.
   Google Scholar
• Carpentier, P.A., Duncan, D.S., Miller, S.D. (2008). Glial toll-like receptor signaling in central nervous system infection and autoimmunity. Brain Behav. Immun. 22:140–147.
   PubMed Web of Science ®Google Scholar
• Chao, C.C., Hu, S., Molitor, T.W., Shaskan, E.G., Peterson, P.K. (1992). Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J. Immunol. 149:2736–2741.
   PubMed Web of Science ®Google Scholar
• De Miranda, J., Yaddanapudi, K., Hornig, M., Lipkin, W.I. (2009). Astrocytes recognize intracellular polyinosinic-polycytidylic acid via MDA-5. FASEB J. 23:1064–1071.
   Google Scholar
• Dong, Y., Benveniste, E.N. (2001). Immune function of astrocytes. Glia 36:180–190.
   PubMed Web of Science ®Google Scholar
• Doyle, S., Vaidya, S., O’Connell, R., Dadgostar, H., Dempsey, P., Wu, T., Rao, G., Sun, R., Haberland, M., Modlin, R., Cheng, G. (2002). IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 17:251–263.
   PubMed Web of Science ®Google Scholar
• El-Hage, N., Gurwell, J.A., Singh, I.N., Knapp, P.E., Nath, A., Hauser, K.F. (2005). Synergistic increase in intracellular Ca2+, and the release of MCP-1, RANTES and IL-6 by astrocytes treated with opiates and HIV-1 Tat. Glia 50:91–106.
   PubMedGoogle Scholar
• El-Hage, N., Wu, G., Wang, J., Ambati, J., Knapp, P.E., Bruce-Keller, A., Hauser, K.F. (2006a). HIV Tat1-72aa and Opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines. Glia 53:132–146.
   Web of Science ®Google Scholar
• El-Hage, N., Wu, G., Ambati, J., Bruce-Keller, A., Knapp, P.E., Hauser, K.F. (2006b). CCR2 mediates increases in glial activation caused by exposure to HIV-1 Tat and opiates. J. Neuroimmunol. 178:9–16.
   Web of Science ®Google Scholar
• El-Hage, N., Bruce-Keller, A.J., Knapp, P.E., Hauser, K.F. (2008a). CCL5/RANTES gene deletion attenuates opioid-induced increases in glial CCL2/MCP-1 immunoreactivity and activation in HIV-1 Tat-exposed mice. J. Neuroimmun. Pharmacol. 3:275–285.
   Google Scholar
• El-Hage, N., Bruce-Keller, A.J., Yakovleva, T., Bazov, I., Bakalkin, G., Knapp, P.E., Hauser, K.F. (2008b). Morphine exacerbates HIV-1 Tat-induced cytokine production in astrocytes through convergent effects on [Ca2+]i, NF-kappaB trafficking and transcription. PLoS One 3:e4093.
   PubMed Web of Science ®Google Scholar
• Equils, O., Faure, E., Thomas, L., Bulut, Y., Trushin, S., Arditi, M. (2001). Bacterial lipopolysaccharide activates HIV long terminal repeat through Toll-like receptor 4. J. Immunol. 166:2342–2347.
   PubMedGoogle Scholar
• Equils, O., Schito, M.L., Karahashi, H., Madak, Z., Yarali, A., Michelsen, K.S., Sher, A., Arditi, M. (2003). Toll-like receptor 2 (TLR2) and TLR9 signaling results in HIV-long terminal repeat trans-activation and HIV replication in HIV-1 transgenic mouse spleen cells: Implications of simultaneous activation of TLRs on HIV replication. J. Immunol. 170:5159–5164.
   PubMedGoogle Scholar
• Farina, C., Krumbholz, M., Giese, T., Hartmann, G., Aloisi, F., Meinl, E. (2005). Preferential expression and function of Toll-like receptor 3 in human astrocytes. J. Neuroimmunol. 159:12–19.
   Google Scholar
• Farina, C., Aloisi, F., Meinl, E. (2007). Astrocytes are active players in cerebral innate immunity. Trends Immunol. 28:138–145.
   PubMed Web of Science ®Google Scholar
• Fitting, S., Zou, S., Chen, W., Vo, P., Hauser, K.F., Knapp, P.E. (2010). Regional Heterogeneity and diversity in cytokine and chemokine production by astroglia: Differential responses to HIV-1 Tat, gp120 and morphine revealed by multiplex analysis. J. Proteome Res. 9:1795–1804.
   Web of Science ®Google Scholar
• Fuller, S., Steele, M., Munch, G. (2009). Activated astroglia during chronic inflammation in Alzheimer’s disease—Do they neglect their neurosupportive roles? Mutat. Res. Sep. 11 [Epub ahead of print].
   Google Scholar
• Gendelman, H.E., Persidsky, Y., Ghorpade, A., Limoges, J., Stins, M., Fiala, M., Morrisett, R. (1997). The neuropathogenesis of the AIDS dementia complex. AIDS 11 Suppl A:S35–S45.
   Google Scholar
• Gill, N., Deacon, P.M., Lichty, B., Mossman, K.L., Ashkar, A.A. (2006). Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production. J. Virol. 80:9943–9950.
   Google Scholar
• Griess, P. (1879). Bemernkugen zu der Abhandlung der HH: Wesely und Benedikt “Ueber einige Azoverbindungen”. Ber. Dtsch. Chem. Ges. 12:426–428.
   Google Scholar
• Hauser, K.F., El-Hage, N., Stiene-Martin, A., Maragos, W.F., Nath, A., Persidsky, Y., Volsky, D.J., Knapp, P.E. (2007). HIV-1 neuropathogenesis: Glial mechanisms revealed through substance abuse. J. Neurochem. 100:567–586.
   PubMed Web of Science ®Google Scholar
• Heggelund, L., Muller, F., Lien, E., Yndestad, A., Ueland, T., Kristiansen, K.I., Espevik, T., Aukrust, P., Froland, S.S. (2004a). Increased expression of toll-like receptor 2 on monocytes in HIV infection: possible roles in inflammation and viral replication. Clin. Infect. Dis. 39:264–269.
   PubMed Web of Science ®Google Scholar
• Heggelund, L., Flo, T., Berg, K., Lien, E., Mollnes, T.E., Ueland, T., Aukrust, P., Espevik, T., Froland, S.S. (2004b). Soluble toll-like receptor 2 in HIV infection: association with disease progression. AIDS 18:2437–2439.
   PubMed Web of Science ®Google Scholar
• Hutchinson, M.R., Bland, S.T., Johnson, K.W., Rice, K.C., Maier, S.F., Watkins, L.R. (2007). Opioid-induced glial activation: Mechanisms of activation and implications for opioid analgesia, dependence, and reward. Sci. World J. 7: 98–111.
   Google Scholar
• Hutchinson, M.R., Zang, Y., Brown, K., Coats, B.D., Shridhar, M., Sholar, P.W., Patel, S.J., Crysdale, N.Y., Harrison, J.A., Maier, S.F., Rice, K.C., Watkins, L.R. (2008). Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4). Eur. J. Neurosci. 28:20–29.
   PubMed Web of Science ®Google Scholar
• Iwasaki, A., Medzhitov, R. (2010). Regulation of adaptive immunity by the innate immune system. Science 327:291–295.
   PubMed Web of Science ®Google Scholar
• Jack, C.S., Arbour, N., Manusow, J., Montgrain, V., Blain, M., McCrea, E., Shapiro, A., Antel, J.P. (2005). TLR signaling tailors innate immune responses in human microglia and astrocytes. J. Immunol. 175:4320–4330.
   PubMed Web of Science ®Google Scholar
• Kariko, K., Weissman, D., Welsh, F.A. (2004). Inhibition of toll-like receptor and cytokine signaling—A unifying theme in ischemic tolerance. J. Cereb. Blood Flow Metab. 24: 1288–1304.
   PubMedGoogle Scholar
• Kaul, M., Garden, G.A., Lipton, S.A. (2001). Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410:988–994.
   PubMed Web of Science ®Google Scholar
• Kaul, M., Ma, Q., Medders, K.E., Desai, M.K., Lipton, S.A. (2007). HIV-1 coreceptors CCR5 and CXCR4 both mediate neuronal cell death but CCR5 paradoxically can also contribute to protection. Cell Death Differ. 14:296–305.
   PubMed Web of Science ®Google Scholar
• Laflamme, N., Rivest, S. (2001). Toll-like receptor 4: the missing link of the cerebral innate immune response triggered by circulating gram-negative bacterial cell wall components. FASEB J. 15:155–163.
   PubMed Web of Science ®Google Scholar
• Lafon, M., Megret, F., Lafage, M., Prehaud, C. (2006). The innate immune facet of brain: human neurons express TLR-3 and sense viral dsRNA. Mol. Neurosci. 29:185–94.
   PubMed Web of Science ®Google Scholar
• Lander, H.M., Ogiste, J.S., Pearce, S.F., Levi, R., Novogrodsky, A. (1995). Nitric oxide-stimulated guanine nucleotide exchange on p21ras. J. Biol. Chem. 270:7017–7020.
   PubMed Web of Science ®Google Scholar
• Li, Y., Sun, X., Zhang, Y., Huang, J., Hanley, G., Ferslew, K.E., Peng, Y., Yin, D. (2009). Morphine promotes apoptosis via TLR2, and this is negatively regulated by beta-arrestin 2. Biochem. Biophys. Res. Commun. 378:857–861.
   Google Scholar
• Liu, H.C., Anday, J.K., House, S.D., Chang, S.L. (2004). Dual effects of morphine on permeability and apoptosis of vascular endothelial cells: Morphine potentiates lipopolysaccharide-induced permeability and apoptosis of vascular endothelial cells. J. Neuroimmunol. 146:13–21.
   Google Scholar
• Liu, X., Mosoian, A., Li-Yun, C.T., Zerhouni-Layachi, B., Snyder, A., Jarvis, G.A., Klotman, M.E. (2006). Gonococcal lipooligosaccharide suppresses HIV infection in human primary macrophages through induction of innate immunity. J. Infect. Dis. 194:751–759.
   Google Scholar
• MacDonald, E.M., Savoy, A., Gillgrass, A., Fernandez, S., Smieja, M., Rosenthal, K.L., Ashkar, A.A., Kaushic, C. (2007). Susceptibility of human female primary genital epithelial cells to herpes simplex virus, type-2 and the effect of TLR3 ligand and sex hormones on infection. Biol. Reprod. 77:1049–1059.
   Google Scholar
• Martinelli, E., Cicala, C., Van, R.D., Goode, D.J., Macleod, K., Arthos, J., Fauci, A.S. (2007). HIV-1 gp120 inhibits TLR9-mediated activation and IFN-α secretion in plasmacytoid dendritic cells. Proc. Natl. Acad. Sci. USA 104:3396–3401.
   PubMed Web of Science ®Google Scholar
• Martinson, J.A., Tenorio, A.R., Montoya, C.J., Al-Harthi, L., Gichinga, C.N., Krieg, A.M., Baum, L.L., Landay, A.L. (2007). Impact of class A, B and C CpG-oligodeoxynucleotides on in vitro activation of innate immune cells in human immunodeficiency virus-1 infected individuals. Immunol. 120:526–535.
   Google Scholar
• Matsuzawa, A., Saegusa, K., Noguchi, T., Sadamitsu, C., Nishitoh, H., Nagai, S., Koyasu, S., Matsumoto, K., Takeda, K., Ichijo, H. (2005). ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Nat. Immunol. 6:587–592.
   PubMed Web of Science ®Google Scholar
• McGeer, P.L., McGeer, E.G. (2004). Inflammation and the degenerative diseases of aging. Ann. NY Acad. Sci. 1035:104–116.
   PubMed Web of Science ®Google Scholar
• McKimmie, C.S., Fazakerley, J.K. (2005). In response to pathogens, glial cells dynamically and differentially regulate Toll-like receptor gene expression. J. Neuroimmunol. 169:116–125.
   PubMed Web of Science ®Google Scholar
• Medders, K.E., Sejbuk, N.E., Maung, R., Desai, M.K., Kaul, M. (2010). Activation of p38 MAPK is required in monocytic and neuronal cells for HIV glycoprotein 120-induced neurotoxicity. J. Immunol. 185:4883–4895.
   Web of Science ®Google Scholar
• Medzhitov, R., Janeway, C.A. (1999). Innate immune induction of the adaptive immune response. Cold Spring Harb. Symp. Quant. Biol. 64:429–435.
   PubMedGoogle Scholar
• Mishra, B.B., Mishra, P.K., Teale, J.M. (2006). Expression and distribution of Toll-like receptors in the brain during murine neurocysticercosis. J. Neuroimmunol. 181:46–56.
   PubMed Web of Science ®Google Scholar
• Mustafa, A.K., Gadalla, M.M., Snyder, S.H. (2009). Signaling by gasotransmitters. Sci. Signal 2: re2.
   PubMed Web of Science ®Google Scholar
• Nath, A., Hauser, K.F., Wojna, V., Booze, R.M., Maragos, W., Prendergast, M., Cass, W., Turchan, J.T. (2002). Molecular basis for interactions of HIV and drugs of abuse. J. Acquir. Immune Defic. Syndr. 31 Suppl 2:S62–S69.
   PubMed Web of Science ®Google Scholar
• O’Hara, S.P., Small, A.J., Gajdos, G.B., Badley, A.D., Chen, X.M., Larusso, N.F. (2009). HIV-1 Tat protein suppresses cholangiocyte toll-like receptor 4 expression and defense against Cryptosporidium parvum. J. Infect. Dis. 199:1195–1204.
   Google Scholar
• Park, C., Lee, S., Cho, I.-H., Lee, H.-K., Kim, D., Choi, S.-Y., Oh, S.-B., Park, K., Kim, J.-S., Lee, S.-J. (2006). TLR 3-mediated signal induces proinflammatory cytokine and chemokine gene expression in astrocytes: differential signaling mechanisms of TLR3-induced IP-10 and IL-8 gene expression. Glia 53:248–256.
   PubMed Web of Science ®Google Scholar
• Phulwani, N.K., Esen, N., Syed, M.M., Kielian, T. (2008). TLR2 expression in astrocytes is induced by TNF-alpha- and NF-kappa B-dependent pathways. J. Immunol. 181:3841–3849.
   Google Scholar
• Rao, K.M. (2001). MAP kinase activation in macrophages. J Leukoc Biol 69:3–10.
   PubMed Web of Science ®Google Scholar
• Rivieccio, M.A., Suh, H.S., Zhao, Y., Zhao, M.L., Chin, K.C., Lee, S.C., Brosnan, C.F. (2006). TLR3 ligation activates an antiviral response in human fetal astrocytes: A role for viperin/cig5. J. Immunol. 177:4735–4741.
   PubMed Web of Science ®Google Scholar
• Ryan, K.A., Smith, M.F., Jr., Sanders, M.K., Ernst, P.B. (2004). Reactive oxygen and nitrogen species differentially regulate Toll-like receptor 4-mediated activation of NF-kappa B and interleukin-8 expression. Infect. Immun. 72:2123–2130.
   PubMed Web of Science ®Google Scholar
• Salaria, S., Badkoobehi, H., Rockenstein, E., Crews, L., Chana, G., Masliah, E., Everall, I.P., and the HNRC Group (2007) Toll-like receptor pathway gene expression is associated with human immunodeficiency virus-associated neurodegeneration. J. NeuroVirol. 13:496–503.
   Web of Science ®Google Scholar
• Sanghavi, S.K., Reinhart, T.A. (2005). Increased expression of TLR3 in lymph nodes during simian immunodeficiency virus infection: Implications for inflammation and immunodeficiency. J. Immunol. 175:5314–5323.
   Google Scholar
• Scheller, C., Ullrich, A., McPherson, K., Hefele, B., Knoferle, J., Lamla, S., Olbrich, A.R., Stocker, H., Arasteh, K. ter M.V., Rethwilm, A., Koutsilieri, E., Dittmer, U. (2004). CpG oligodeoxynucleotides activate HIV replication in latently infected human T cells. J. Biol. Chem. 279:21897–21902.
   PubMed Web of Science ®Google Scholar
• Schlaepfer, E., Audige, A., von, B.B., Manolova, V., Weber, M., Joller, H., Bachmann, M.F., Kundig, T.M., Speck, R.F. (2004). CpG oligodeoxynucleotides block human immunodeficiency virus type 1 replication in human lymphoid tissue infected ex vivo. J. Virol. 78:12344–12354.
   PubMed Web of Science ®Google Scholar
• Schlaepfer, E., Audige, A., Joller, H., Speck, R.F. (2006). TLR7/8 triggering exerts opposing effects in acute versus latent HIV infection. J. Immunol. 176:2888–2895.
   PubMed Web of Science ®Google Scholar
• Scumpia, P.O., Kelly, K.M., Reeves, W.H., Stevens, B.R. (2005). Double-stranded RNA signals antiviral and inflammatory programs and dysfunctional glutamate transport in TLR3-expressing astrocytes. Glia 52:153–162.
   PubMed Web of Science ®Google Scholar
• Sheng, W.S., Hu, S., Gekker, G., Zhu, S., Peterson, P.K., Chao, C.C. (1997). Immunomodulatory role of opioids in the central nervous system. Arch. Immunol. Ther. Exp. (Warsz) 45:359–366.
   PubMedGoogle Scholar
• Stiene-Martin, A., Zhou, R., Hauser, K.F. (1998). Regional, developmental, and cell cycle-dependent differences in μ, δ and k-opioid receptor expression among cultured mouse astrocytes. Glia 22:249–259.
   PubMed Web of Science ®Google Scholar
• Suh, H.S., Brosnan, C.F., Lee, S.C. (2009). Toll-like receptors in CNS viral infections. Curr. Top. Microbiol. Immunol. 336:63–81.
   Google Scholar
• Sundstrom, J.B., Little, D.M., Villinger, F., Ellis, J.E., Ansari, A.A. (2004). Signaling through Toll-like receptors triggers HIV-1 replication in latently infected mast cells. J. Immunol. 172:4391–4401.
   PubMed Web of Science ®Google Scholar
• Suzuki, Y.J., Forman, H.J., Sevanian, A. (1997). Oxidants as stimulators of signal transduction. Free Radic. Biol. Med. 22:269–285.
   PubMed Web of Science ®Google Scholar
• Takeda, K., Kaisho, T., Akira, S (2003). Toll-like receptors. Annu. Rev. Immunol. 21:335–376.
   PubMed Web of Science ®Google Scholar
• Tsan, M.F., Gao, B. (2004). Endogenous ligands of Toll-like receptors. J. Leukoc. Biol. 76:514–519.
   PubMed Web of Science ®Google Scholar
• Wang, J., Barke, R.A., Charboneau, R., Schwendener, R., Roy, S. (2008). Morphine induces defects in early response of alveolar macrophages to Streptococcus pneumoniae by modulating TLR9-NF-kappa B signaling. J. Immunol. 180:3594–3600.
   PubMed Web of Science ®Google Scholar
• Watkins, L.R., Hutchinson, M.R., Rice, K.C., Maier, S.F. (2009). The “toll” of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia. Trends Pharmacol. Sci. 30(11):581–591.
   Google Scholar
• Yamamoto, M., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Sanjo, H., Takeuchi, O., Sugiyama, M., Okabe, M., Takeda, K., Akira, S. (2003). Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301:640–643.
   PubMed Web of Science ®Google Scholar
• Zekki, H., Feinstein, D.L., Rivest, S. (2002). The clinical course of experimental autoimmune encephalomyelitis is associated with a profound and sustained transcriptional activation of the genes encoding toll-like receptor 2 and CD14 in the mouse CNS. Brain Pathol. 12:308–319.
   PubMed Web of Science ®Google Scholar
• Ziegler, G., Harhausen, D., Schepers, C., Hoffmann, O., Rohr, C., Prinz, V., Konig, J., Lehrach, H., Nietfeld, W., Trendelenburg, G .(2007). TLR2 has a detrimental role in mouse transient focal cerebral ischemia. Biochem. Biophys. Res. Commun. 359:574–579.
   PubMed Web of Science ®Google Scholar